JP2020528888A5 - - Google Patents

Download PDF

Info

Publication number
JP2020528888A5
JP2020528888A5 JP2020502672A JP2020502672A JP2020528888A5 JP 2020528888 A5 JP2020528888 A5 JP 2020528888A5 JP 2020502672 A JP2020502672 A JP 2020502672A JP 2020502672 A JP2020502672 A JP 2020502672A JP 2020528888 A5 JP2020528888 A5 JP 2020528888A5
Authority
JP
Japan
Prior art keywords
composition
iron
salt
iii
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020502672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020528888A (ja
Filing date
Publication date
Priority claimed from IT102017000085412A external-priority patent/IT201700085412A1/it
Application filed filed Critical
Publication of JP2020528888A publication Critical patent/JP2020528888A/ja
Publication of JP2020528888A5 publication Critical patent/JP2020528888A5/ja
Priority to JP2023076299A priority Critical patent/JP2023090869A/ja
Pending legal-status Critical Current

Links

JP2020502672A 2017-07-26 2018-07-26 心血管器官の病態の予防及び処置における使用のための組成物 Pending JP2020528888A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023076299A JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT102017000085412 2017-07-26
PCT/IB2018/055586 WO2019021232A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023076299A Division JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Publications (2)

Publication Number Publication Date
JP2020528888A JP2020528888A (ja) 2020-10-01
JP2020528888A5 true JP2020528888A5 (cg-RX-API-DMAC7.html) 2021-09-02

Family

ID=60451085

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020502672A Pending JP2020528888A (ja) 2017-07-26 2018-07-26 心血管器官の病態の予防及び処置における使用のための組成物
JP2023076299A Pending JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023076299A Pending JP2023090869A (ja) 2017-07-26 2023-05-02 心血管器官の病態の予防及び処置における使用のための組成物

Country Status (19)

Country Link
US (1) US20200206157A1 (cg-RX-API-DMAC7.html)
EP (1) EP3657963A1 (cg-RX-API-DMAC7.html)
JP (2) JP2020528888A (cg-RX-API-DMAC7.html)
KR (1) KR20200032691A (cg-RX-API-DMAC7.html)
CN (1) CN111031813A (cg-RX-API-DMAC7.html)
BR (1) BR112020000902B1 (cg-RX-API-DMAC7.html)
CA (1) CA3070659A1 (cg-RX-API-DMAC7.html)
CL (1) CL2020000170A1 (cg-RX-API-DMAC7.html)
CO (1) CO2020000526A2 (cg-RX-API-DMAC7.html)
EA (1) EA202090069A1 (cg-RX-API-DMAC7.html)
IL (1) IL272138B2 (cg-RX-API-DMAC7.html)
IT (1) IT201700085412A1 (cg-RX-API-DMAC7.html)
JO (1) JOP20200012A1 (cg-RX-API-DMAC7.html)
MA (1) MA49794A (cg-RX-API-DMAC7.html)
MX (1) MX2020000806A (cg-RX-API-DMAC7.html)
PE (1) PE20200794A1 (cg-RX-API-DMAC7.html)
PH (1) PH12020550031A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019021232A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202000461B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
SG11202012070YA (en) 2018-06-08 2021-01-28 Epizon Pharma Inc Methods and compositions for preventing or treating tissue calcification
MX2020013301A (es) 2018-06-08 2021-05-12 Epizon Pharma Inc Metodos y composiciones para prevenir o tratar calcifilaxis.
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007329A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
CN114748486A (zh) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用
WO2023232643A1 (en) 2022-05-31 2023-12-07 Region Syddanmark Vitamin k2 for use in treatment of coronary artery calcification

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3860849B2 (ja) * 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗動脈硬化治療剤
CA2222278C (en) * 1995-06-06 2008-05-13 Campbell Soup Company Mineral supplements for dietetic food
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
AU2004287440A1 (en) * 2003-10-28 2005-05-19 Emory University Dialysates and methods and systems related thereto
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
US20060134226A1 (en) * 2004-11-16 2006-06-22 Todd Leonard Compositions useful to treat ocular neovascular diseases and macular degeneration
ES2634142T3 (es) * 2005-12-23 2017-09-26 Ajay Gupta Composición de nutrición parenteral que contiene hierro
EP1978808B1 (en) * 2006-01-30 2018-08-29 Panion & BF Biotech Inc. Ferric citrate for reversing, preventing, delaying or stabilizing soft tissue calcification
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
JPWO2010073642A1 (ja) * 2008-12-25 2012-06-07 有限会社 アイ・ビー・イー 生物活性剤、医薬、化粧品、鮮度保持剤、および植物および動物の発育促進剤
CN103687495A (zh) * 2011-05-20 2014-03-26 弗里斯兰品牌有限公司 包含维生素k2的组合物
ITMI20121350A1 (it) * 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
EP2886129A1 (en) * 2013-12-20 2015-06-24 VitaK B.V. Prevention and counteraction of diet-induced thrombosis risk
EP3258924A2 (en) * 2015-02-20 2017-12-27 VitaK B.V. Vitamin k and capillary function
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Similar Documents

Publication Publication Date Title
JP2023090869A5 (cg-RX-API-DMAC7.html)
JP5829607B2 (ja) ω3脂肪酸の配合製剤
JP2014077003A5 (cg-RX-API-DMAC7.html)
US20100166918A1 (en) Nutraceuticals containing nitro fatty acids
CA3083327A1 (en) Combination of a 4-pyrimidinesulfamide derivative with an sglt-2 inhibitor for the treatment of endothelin related diseases
JP2016510326A5 (cg-RX-API-DMAC7.html)
JP2014530897A5 (cg-RX-API-DMAC7.html)
JP2016517851A5 (cg-RX-API-DMAC7.html)
EP2792353A3 (en) Compounds and methods for delivery of prostacyclin analogs
JP2016511753A5 (cg-RX-API-DMAC7.html)
IL292262B2 (en) Formulation of an oral administration form of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid
RU2015139225A (ru) Применение производных, содержащих связи с-о-р, у пациентов с почечной недостаточностью
JP2014517001A5 (cg-RX-API-DMAC7.html)
JP2019206562A5 (cg-RX-API-DMAC7.html)
JP2011520855A5 (cg-RX-API-DMAC7.html)
RU2019122735A (ru) Способы и композиции для предотвращения или минимизации эпителиально-мезенхимального перехода
EP3657963A1 (en) Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
FI3664628T3 (fi) Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia
JP2018507260A5 (cg-RX-API-DMAC7.html)
PT1635838E (pt) Inibidores da fosfodiesterase 5 para a profilaxia e/ou terapia da hipertonia portal
JP2018521031A5 (cg-RX-API-DMAC7.html)
KR20220098757A (ko) Bet 브로모도메인 억제제 및 나트륨 의존 글루코스 수송 2 억제제와 병용하여 주요 부정적 심혈관 사건 (mace)을 치료 및/또는 예방하는 방법
JP2017515899A5 (cg-RX-API-DMAC7.html)
JP2009515951A5 (cg-RX-API-DMAC7.html)
JP2016512243A5 (cg-RX-API-DMAC7.html)